• Theranostics: Functional imaging with PCa

    Behind this word lies a new method that combines diagnostics and therapy. In prostate cancer, a PSMA ligand, such as that used in PET/CT, is linked to a radioisotope such as 177 lutetium. This achieves site-specific tumor therapy.

  • HPV infections in men: farewell to fertility?

    With more than 200 known genotypes the human papillomaviruses are not only dermatologically relevant. HPV infection must be regarded as a systemic infection that can also be detected in the testicles or ejaculate of men. But does it also affect fertility?

  • Focal therapy failure: A walk on thin ice

    Focal Therapy (FT) for prostate cancer is considered as an organ-preserving surgical technique with few side effects. However, there is no extensive evidence-based data for its effectiveness and it is still regarded as an experimental procedure.

  • Antibiotics: Is a solution of the resistance problem in sight?

    Overuse, misuse and also the almost exponential use of antibiotics in animal production contribute to antibiotic resistance. Important medications may no longer be usable in the future. The search for antibiotics alternatives has therefore long ago begun.

  • More often than thought: the forgotten stent

    The placement of a stent is a routine task for urologists worldwide. The responsibility to remove this stent also rests on their shoulders. Statistically, however, about 13% of stents are forgotten - with far-reaching consequences for the patients and beyond.

  • Testosterone deficiency increases prostate cancer risk

    Testosterone administration is contraindicated in PCa patients even after radical prostatectomy. But more recent findings in hypogonadal men hint at a slow rehabilitation of testosterone substitution.

  • Urogenital tuberculosis often remains undetected

    Urogenital TB is often overlooked. In regions with high TB prevalence, it is "treated" as a classic UTI. UTIs may mask urogenital tuberculosis frequently, and doctors should be reminded of this scenario.

  • Nephrolithiasis: There are news

    Nephrolithiasis is a frequently treated disease in urology, assumed to have no further room for groundbreaking innovations. However, causal research and the vacuum-assisted mini-percutaneous nephrolithotomy (vmPCNL) hint at new developments.